Pantoprazole sodium delayed-release
Pantoprazole sodium delayed-release is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: Pantoprazole sodium delayed-release; Generic name: PANTOPRAZOLE SODIUM DELAYED-RELEASE; Manufacturer: Lifestar Pharma LLC.
| Brand name | Pantoprazole sodium delayed-release |
|---|---|
| Generic name | PANTOPRAZOLE SODIUM DELAYED-RELEASE |
| Manufacturer | Lifestar Pharma LLC |
| Used for | 1 INDICATIONS AND USAGE Pantoprazole sodium delayed-release tablets are indicated for: Pantoprazole sodium is a proton pump inhibitor (PPI) indicated for the following: Short-Term Treatment of Erosive Esophagitis Associated with Gastroesophageal Reflux Disease (GERD) ( 1.1 ) Maintenance of Healing of Erosive Esophagitis ( 1.2 ) Pathological Hypersecretory Conditions Including Zollinger-Ellison (ZE) Syndrome ( 1.3 ) 1.1 Short-Term Treatment of Erosive Esophagitis Associated With Gastroesophageal Reflux Disease (GERD) Pantoprazole sodium is indicated in adults and pediatric patients five years of age and older for the short-term treatment (up to 8 weeks) in the healing and symptomatic relief o |
| Dosage | 2 DOSAGE AND ADMINISTRATION Indication Dose Frequency Short-Term Treatment of Erosive Esophagitis Associated With GERD (2.1) Adults 40 mg Once Daily for up to 8 weeks Children (5 years and older) ≥15 kg to < 40 kg 20 mg Once Daily for up to 8 weeks ≥ 40 kg 40 mg Maintenance of Healing of Erosive Esophagitis (2.1) Adults 40 mg Once Daily* Pathological Hypersecretory Conditions Including Zollinger-Ellison Syndrome (2.1) Adults 40 mg Twice Daily * Controlled studies did not extend beyond 12 months |
| Active ingredient(s) | PANTOPRAZOLE SODIUM |
| Route | ORAL |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0502f935-af7a-4f1e-8c3e-29e20647c885 |